ClinicalTrials.govpublic full text
Onvansertib + Paclitaxel In TNBC
breast cancer, invasive breast cancer, unresectable breast carcinoma, locally advanced breast cancer, metastatic breast cancer, inflammatory breast cancer, triple negative breast cancer (tnbc), hormone receptor/growth factor receptor-negative breast cancer, her2-negative breast cancer, hormone receptor negative breast carcinoma, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 890749
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.